SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-007852
Filing Date
2022-05-05
Accepted
2022-05-05 16:18:17
Documents
14
Period of Report
2022-05-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K lbph-20220505.htm   iXBRL 8-K 58694
2 EX-99.1 lbph-ex99_1.htm EX-99.1 221248
3 GRAPHIC img58896055_0.jpg GRAPHIC 11946
  Complete submission text file 0000950170-22-007852.txt   440224

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lbph-20220505.xsd EX-101.SCH 2521
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lbph-20220505_pre.xml EX-101.PRE 12097
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lbph-20220505_lab.xml EX-101.LAB 18544
8 EXTRACTED XBRL INSTANCE DOCUMENT lbph-20220505_htm.xml XML 5114
Mailing Address 4275 EXECUTIVE SQUARE SUITE 950 LA JOLLA CA 92037
Business Address 4275 EXECUTIVE SQUARE SUITE 950 LA JOLLA CA 92037 619-592-9775
Longboard Pharmaceuticals, Inc. (Filer) CIK: 0001832168 (see all company filings)

IRS No.: 845009619 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40192 | Film No.: 22896568
SIC: 2834 Pharmaceutical Preparations